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Imprinted genes, which are monoallelically expressed by virtue of an epigenetic process initiated in the
germline, are known to play key roles in regulating fetal growth and placental development. Numerous
studies are investigating the expression of these imprinted genes in the human placenta in relation to
common complications of pregnancy such as fetal growth restriction and preeclampsia. This study aimed
to determine whether placental sampling protocols or other factors such as fetal sex, gestational age and
mode of delivery may inﬂuence the expression of imprinted genes predicted to regulate placental
signalling.
Methods: Term placentas were collected from Caucasian women delivering at University Hospital of
Wales or Royal Gwent Hospital within two hours of delivery. Expression of the imprinted genes PHLDA2,
CDKN1C, PEG3 and PEG10 was assayed by quantitative real time PCR. Intraplacental gene expression was
analysed (N ¼ 5). Placental gene expression was compared between male (N ¼ 11) and female (N ¼ 11)
infants, early term (N ¼ 8) and late term (N ¼ 10) deliveries and between labouring (N ¼ 13) and non-
labouring (N ¼ 21) participants.
Results: The paternally expressed imprinted genes PEG3 and PEG10 were resilient to differences in
sampling site, fetal sex, term gestational age and mode of delivery. The maternally expressed imprinted
gene CDKN1C was elevated over 2-fold (p < 0.001) in placenta from labouring deliveries compared with
elective caesarean sections. In addition, the maternally expressed imprinted gene PHLDA2 was elevated
by 1.8 fold (p ¼ 0.01) in samples taken at the distal edge of the placenta compared to the cord insertion
site.
Conclusion: These ﬁndings support the reinterpretation of existing data sets on these genes in relation to
complications of pregnancy and further reinforce the importance of optimising and unifying placental
collection protocols for future studies.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Imprinted genes display parent of origin speciﬁc gene expres-
sion [1] and play a key role in regulating placental development and
controlling fetal growth (reviewed in Ref. [2]). Recent studies have
identiﬁed several imprinted genes that regulate the endocrine
lineages of the mouse placenta to modulate placental hormone
production (reviewed in Ref. [3]). Imprinting of four of these genes,.
r Ltd. This is an open access articlePLECKSTRIN HOMOLOGY-LIKE DOMAIN FAMILY A MEMBER 2
(PHLDA2), CYCLIN-DEPENDENT KINASE INHIBITOR 1C (CDKN1C),
PATERNALLY EXPRESSED GENE 3 (PEG3) and PATERNALLY EXPRESSED
GENE 10 (PEG10), is conserved in the human placenta [4]. While a
number of studies have examined human placental imprinted gene
expression focusing primarily on fetal growth restriction (FGR) as
an adverse outcome [4e9], the potential for aberrant placental
signalling presents additional implications for human pregnancies.
Gene expression in the placenta can be inﬂuenced by many
factors including differences in sampling site, fetal sex, gestational
age and mode of delivery (reviewed in Ref. [10]). Variation in gene
expression may occur in different regions of the placenta due tounder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Characteristics of the study participants (N ¼ 40). Mean (SD)/range or number (%)
is shown.
Study Participants (N ¼ 40)
Maternal Characteristic
Ethnicity:
Caucasian 40 (100%)
Parity 1 (0.87)/0e3
Maternal age 30 (6.12)/19e40
Maternal BMI 27 (5.91)/17 - 38
Birth Outcome
Mode of Delivery:
Vaginal 9 (22%)
Elective C section 27 (68%)
Emergency C section 4 (10%)
Birth weight (g) 3417 (303)/2680 - 4030
Gestational age (weeks) 39 (1.19)/37 - 42
Placental weight (g) 676 (120)/434 - 891
Gender
Male 18 (45%)
Female 22 (55%)
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consistency in placental sampling is of key importance [10]. A
number of studies have demonstrated differences in intraplacental
gene expression depending on sampling site [11e17] but the pos-
sibility of intraplacental variation in expression of PHLDA2, CDKN1C,
PEG3 or PEG10 has not been investigated.
Sexual dimorphism in humanplacental gene expression (of both
autosomal and sex chromosome linked genes) has also previously
been demonstrated [17,18] which has been proposed to underlie
sex differences in fetal growth [19]. As sexual dimorphism in
placental imprinted gene expression has been demonstrated in an
animal model [20] and for the imprinted H19 gene in human
placenta [9], controlling for fetal sex is important to studies of
imprinted gene expression in the human placenta.
Infant morbidity and mortality [21e23] as well as placental
pathology [24] have been observed to vary in response to gesta-
tional age in term pregnancies. It has therefore been proposed that
infants should be distinguished as early term (37 0/7 to 38 6/7
weeks) and full term (39 0/7 to 41 6/7) [23]. While it has been
demonstrated that placental expression of PHLDA2 varies between
preterm and term deliveries [7], it has not yet been established
whether expression of PHLDA2, CDKN1C, PEG3 or PEG10 varies be-
tween early term and full term placentas. This is of particular
relevance to the study of pregnancy complications such as FGR, as
these growth restricted infants may require earlier delivery [25].
Importantly, a number of studies have reported differences in
gene expression between labouring and non-labouring placentas
[26e29], which may arise from a decrease in placental oxygen
supply during contractions [10] and/or differences in exposure to
hormones associated with labour [30]. PHLDA2 is known to be
responsive to hypoxia [31e33] but it is not known whether
placental expression of PHLDA2, CDKN1C, PEG3 or PEG10 is altered
in response to labour.
To address this lack of information, this study examined placental
expression of thematernally expressed imprinted genes PHLDA2 and
CDKN1C and the paternally expressed imprinted genes PEG3 and
PEG10 to determine whether their expression varied in relation to
sampling site, fetal sex, gestational age or mode of delivery.
2. Methods
2.1. Study participants
Study participants (N ¼ 40) were recruited prior to delivery at
University Hospital Wales, Cardiff and Royal Gwent Hospital,
Newport. Written informed consent was obtained and the study
was approved by the South East Wales Research Ethics Committee
(REC number: 10/WSE02/10). Healthy Caucasian women with
singleton pregnancies and no known medical disorders were
recruited and all infants were delivered normal birth weight at
term (37 weeks). Information on birth outcomes were obtained
from the maternal medical notes.
In order to determine the effect of fetal sex on placental
imprinted gene expression, gene expression was compared be-
tween male (N ¼ 11) and female (N ¼ 11) placentas delivered by
elective C-section. Gene expression was also compared between
early term (N ¼ 8) and full term (N ¼ 10) placentas delivered by
elective C-section to determine whether expression varies with
gestational age at term. Finally, to determinewhether labour effects
placental imprinted gene expression, gene expression was
compared between placentas delivered by elective C-section in the
absence of labour (N ¼ 21) and by vaginal (N ¼ 9) or emergency C-
section delivery following a period of labour (N ¼ 4). Allocation of
participants to each group and participant characteristics is sum-
marized in Supplementary Table 1.2.2. Placental dissection
Placentas were weighed and dissected within 2 h of delivery.
Villous trophoblast samples were obtained at ﬁve random sites on
thematernal surface of the placenta, midway between the cord and
distal edge. Samples were thoroughly rinsed in ice cold phosphate
buffered saline to remove excess blood. Placental samples were
then stored in RNAlater (SigmaeAldrich, Dorset, UK) at 4 C prior to
long term storage at 80 C.
To examine intraplacental variation in imprinted gene expres-
sion, three placental samples (close to the cord insertion, middle
and distal edge) were taken from each of the fetal, middle and
maternal layers of the placenta as described by Wyatt et al. (2005)
(16). This was carried out for ﬁve term placentas (2 male, 3 female)
from elective C-sections. Average placental gene expression (fetal,
middle and maternal layers of the placenta) was compared be-
tween sampling sites close to the cord insertion and at distal sites.
Similarly, average placental gene expression (cord insertion, middle
and distal edge) was compared between basal and chorionic sur-
face sampling sites.
2.3. Gene expression analysis
Total RNAwas extracted from the placental tissue samples using
GenElute Mammalian Total RNA Miniprep Kit (SigmaeAldrich,
Dorset, UK) with an on-column DNase digestion (SigmaeAldrich,
Dorset, UK). 5 mg of RNA was reverse transcribed using M-MuLV
reverse transcriptase (Promega, Southampton, UK) with random
hexamers, according to manufacturer's instructions.
Quantitative RT-PCR was performed using Chromo 4 Four
Colour Real Time Detector (MJ Research) in a 20 ml reaction con-
taining 5 ml of cDNA (diluted 1 in 50), 1X Buffer 2 mMMgCl2, 2 mM
dNTPs, 0.65 Units Taq (Fermentas (Thermo), Loughborough, UK),
1 mM of each primer (SigmaeAldrich, Dorset, UK) and 0.12X Sybr
Green (Invitrogen, Paisley, UK). All samples were run in triplicate
and duplicate plates were performed. Conditions for ampliﬁcation
were: 1) 15 min at 94 C, 2) 30 s at 94 C, 3) 30 s at 60 C, 4) 30 s at
72 C and 5) 30 s 75 C, with steps 2e5 repeated for a total of 40
cycles. Melt Curve was performed from 70 C to 94 C, reading
every 0.5 C and holding for 2 s.
Primer sequences were as follows: YWHAZ forward:
TTCTTGATCCCCAATGCTTC and reverse: AGTTAAGGGCCAGACCCAGT,
PHLDA2 forward: GAGCGCACGGGCAAGTA and reverse: CAGCG-
GAAGTCGATCTCCTT [6], CDKN1C forward: CCCATCTAGCTTG-
CAGTCTCTT and reverse: CAGACGGCTCAGGAACCATT [4], PEG3
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GACTGGTGCTTG, PEG10 forward: AAATTGCCTGACATGAAGAGGAGT-
CTA and reverse: AAGCCTAGTCACCACTTCAAAACACACTAAA [4].
Gene expression data is presented as the DCT (target gene
expression relative to the housekeeping gene YWHAZ) and as the
fold change in expression, calculated using the 2DDCT [34] where
the DDCT is the target gene expression relative to expression in the
control group. The housekeeping gene YWHAZ was chosen as this
gene has been demonstrated in a number of studies to be stably
expressed in the human placenta of normal pregnancies [35e37]
and in pregnancies complicated by growth restriction [38]. In the
current study there was no signiﬁcant effect of fetal sex (p ¼ 0.56),
early term delivery (p ¼ 0.44) or labour (p ¼ 0.74) on placental
YWHAZ gene expression.
2.4. Statistical analysis
All statistical analysis was carried out using IBM SPSS Statistics
for Windows (version 20.0, 2011). A ShapiroeWilk test was used to
test for normal distribution of the data. All gene expression data
was normally distributed and therefore differences in gene
expression were analysed using an independent samples T-test.
3. Results
A summary of participant demographics is shown in Table 1.
3.1. Sampling site variation
Placental CDKN1C, PEG3 and PEG10 expression did not differ
signiﬁcantly between cord insertion and distal sampling sites
(Fig. 1A) or between the basal and chorionic surface (Fig. 1B).
Placental PHLDA2 expressionwas signiﬁcantly increased, by 77%, in0
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Fig. 1. Effect of sampling site on placental imprinted gene expression. Gene expression is
of the placenta. Mean fold gene expression is shown (±SEM). Three samples were taken a
expression were analysed using an independent samples t-test. *p < 0.05.samples taken at distal sampling sites compared with sampling
sites close to the cord insertion (Fig. 1A). There was no signiﬁcant
difference in PHLDA2 expression between sampling sites on the
basal and chorionic placental surface (Fig. 1B).
3.2. Fetal sex
There was no signiﬁcant difference in mean placental weight
(663 g vs. 726 g; p¼ 0.23), birth weight (3381 g vs. 3601 g; p¼ 0.07)
or gestational age (273 days v 274 days; p ¼ 0.85) between male
and female infants. There was no signiﬁcant difference in placental
PHLDA2, CDKN1C, PEG3 or PEG10 expression between male and
female placentas (Fig. 2).
3.3. Gestational age
Early term infants were delivered between 37 and 38 weeks
(mean gestational age 266 days) and full term infants between 39
and 40 weeks (mean gestational age 277 days). There was no sig-
niﬁcant difference in mean placental weight (648 g vs. 717 g;
p ¼ 0.23), birth weight (3445 g vs. 3392 g; p ¼ 0.07) between early
term and full term infants. The proportion of male and female in-
fants was also not signiﬁcantly different between early (4 Male, 4
Female) and full term (4Male and 6 Female) participants (p¼ 0.67).
PHLDA2, CDKN1C, PEG3 and PEG10 expression was not signiﬁcantly
altered in early term compared with full term placentas (Fig. 3).
3.4. Labour
There was no signiﬁcant difference in mean placental weight
(708 g vs. 661 g; p¼ 0.31), birth weight (3470 g vs. 3451 g; p¼ 0.85)
or gestational age (273 days v 276 days; p ¼ 0.49) between
labouring and non-labouring participants. There was also no4
Series1
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Series1
Series2
PEG10
Basal surface
Chorionic surface
PEG10
Cord insertion 
Distal edge
shown relative to sampling site near the cord insertion (A) and on the basal surface (B)
t each site for a total of ﬁve placentas (N ¼ 15 samples per site). Differences in gene
Fig. 2. Sex differences in placental imprinted gene expression. Mean fold gene expression is shown (±SEM) relative to expression in male placentas. Differences in gene
expression were not statistically signiﬁcant using an independent samples t-test.
Fig. 3. Early term delivery and placental imprinted gene expression. Mean fold gene expression is shown (±SEM) relative to expression in full term placentas. Differences in gene
expression were not statistically signiﬁcant using an independent samples T-test.
Fig. 4. Effect of labour on placental imprinted gene expression. Mean fold gene expression is shown (±SEM) relative to expression in placentas from elective C section deliveries.
Differences in gene expression were analysed using an independent samples T-test. ***p < 0.001.
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between labouring (6 Male, 7 Female) and non-labouring (11 Male,
10 Female) participants (p ¼ 0.72).
There was no signiﬁcant effect of labour on placental PHLDA2,
PEG3 or PEG10 expression (Fig. 4). Placental CDKN1Cwas increased,
by 140%, in labouring compared with non-labouring participants
(Fig. 4). This increase in placental CDKN1C expression remained
signiﬁcant when labouring participants were divided into those
delivering vaginally (115% increase, p ¼ 0.001, n ¼ 9) and those
delivering by emergency C-section (197% increase, p¼ 0.001, n¼ 4).4. Discussion
This study demonstrates that both the site of sampling and the
mode of delivery can inﬂuence the quantitative assessment of
imprinted gene expression in the human placenta.
Our ﬁrst key ﬁnding was that the expression of PHLDA2 varied
with site of sampling. PHLDA2 is a maternally expressed imprinted
gene whose elevated placental expression has been reported in
relation to fetal growth restriction in several human studies [39]. In
mice we have shown that transgenically elevated Phlda2 drives a
A.B. Janssen et al. / Placenta 36 (2015) 790e795794late and asymmetric fetal growth restriction [40] suggesting a
causal role for PHLDA2 in human fetal growth restriction. In this
current study, we found that placental PHLDA2 expression differed
signiﬁcantly with sampling site, with increased expression at distal
sampling sites compared with sites close to the umbilical cord.
Although no previous study has examined placental PHLDA2
expression in relation to sampling site, a number of studies have
similarly reported signiﬁcant intraplacental variation in gene
expression [12e14,16,17]. Given that placental PHLDA2 expression
is altered in response to hypoxia [31e33], it is possible that differ-
ences in perfusion between distal sites and sites close to the um-
bilical cord [14,16] could underlie the differences in expression
observed. The ﬁnding of intraplacental variation in PHLDA2
expression is novel and has implications for interpretation of pre-
vious studies and for future studies with consistency in placental
sampling of key importance.
A second key ﬁnding in this study was the variation in CDKN1C
in relation to mode of delivery. In humans, loss of expression of
CDKN1C has been linked to the childhood overgrowth disorder
Beckwith Weidemann Syndrome while microduplications span-
ning the gene and alterations in the PCNA domain of CDKN1C have
been linked to the growth restriction disorders Silver-Russell syn-
drome (SRS) and IMAGe syndrome, respectively [41]. Mouse
studies demonstrate that Cdkn1c functions early in life to limit fetal
growth and to regulate placental development [42e45] consistent
with a role for this gene in these disorders.
Loss of function of CDKN1Cmay also play a role in preeclampsia/
HELLP syndrome [46] which has also been partially supported by
animal studies [47]. However, while one study reported signiﬁ-
cantly reduced CDKN1C expression in preeclamptic placentas [48]
two other studies reported signiﬁcantly elevated expression
[49,50]. In the study by Kawasaki et al. [48], placental villous
samples were obtained immediately after caesarean section in the
absence of labour for both controls and preeclampsia pregnancies
that would exclude mode of delivery as a confounder. In the study
by Enquobahrie et al. [50] preeclamptic pregnancies had a higher
caesarean delivery rate but a similar rate of labour with controls
while in the study by Unek et al. [49] placenta were sampled after
caesarean delivery without stating whether labour was initiated.
Similarly, studies examining placental CDKN1C expression in rela-
tion to fetal growth restriction have reported conﬂicting results
with both unaltered [4], increased [5] and decreased [51] expres-
sion reported in FGR placentas which may result from a failure to
control for mode of delivery in these analyses.
In this study, the expression of CDKN1C varied in response to
mode of delivery with both vaginally delivered and emergency
caesarean placenta expressing CDKN1C at signiﬁcantly higher levels
than placenta obtained by elective caesarean in which labour was
not initiated. This is consistent with previous reports of signiﬁ-
cantly increased CDKN1C expression in the mouse uterus and hu-
man myometrium in association with labour [52]. In light of these
new ﬁndings, it will be important to re-examine the data both from
studies reporting a link between placental CDKN1C and pre-
eclampsia or fetal growth restriction and those studies ﬁnding no
association.
No signiﬁcant difference was observed in placental PHLDA2,
PEG3 or PEG10 expression in response to labour, and no intra-
placental variation was observed in placental CDKN1C, PEG3 or
PEG10 expression at different sampling sites. None of the four genes
showed a signiﬁcant difference in expression between early and
late term deliveries and there was no signiﬁcant difference in
relation to fetal sex conﬁrming the ﬁndings of Moore et al. [9].
However, sexual dimorphism exists in the human fetal response to
an adverse environment (reviewed in Ref. [19]) and differential
imprinted gene expression has been reported in male and femalemouse placentas in response to maternal diet alteration [53]. Thus,
a sex-speciﬁc response in human placental imprinted gene
expression to an adverse intrauterine environment merits further
investigation.
In conclusion, we have found that the expression of PHLDA2
varied with sampling site and that expression of CDKN1C varied
with mode of delivery. These types of study further highlight the
importance of developing uniform collection protocols with details
on mode of delivery as well as birth outcomes [10].
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